The large pharmaceutical company had recalled its lung drug Thelin after studies showed it was linked to potentially life-threatening liver damage.
FORBES: Magazine Article
2.
Their question: Why had the U.S. Food and Drug Administration delayed approving Encysive's Thelin, keeping the key drug off the market for another year?